SCHEMBL20093558

SCHEMBL20093558

Cc1cc(-c2n[nH]c3ncnc(N)c23)ccc1N1CCOCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 1/20 0.43
KIT P10721 1/20 0.43
PDGFRA P16234 1/20 0.43
FLT1 P17948 1/20 0.43
FLT4 P35916 1/20 0.43
KDR P35968 1/20 0.43
FLT3 P36888 1/20 0.43
PDE3B Q13370 1/20 0.43
PDE3A Q14432 1/20 0.43
STK4 Q13043 3/20 0.41
STK3 Q13188 3/20 0.41
LRRK2 Q5S007 9/20 0.41
PIK3R1 P27986 1/20 0.41
PIK3CA P42336 1/20 0.41
MTOR P42345 1/20 0.41
DGAT1 O75907 1/20 0.39
BRAF P15056 1/20 0.38
TNNI3K Q59H18 1/20 0.38
GAA P10253 2/20 0.38
KDM4E B2RXH2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13718043 0.88 MAPT (0.47) STK4STK3LRRK2BRAFGAA
SCHEMBL13718282 0.87 PDE3B (0.44) PDE3BPDE3ASTK4STK3LRRK2
SCHEMBL26973905 0.79 ADK (0.54) KDM4EALDH1A1HPGDALOX15SMN1; SMN2
SCHEMBL13718230 0.76 PDE3B (0.44) PDE3BPDE3ASTK4STK3LRRK2
SCHEMBL13718314 0.75 PDE3B (0.42) PDE3BPDE3ASTK4STK3LRRK2
SCHEMBL13826604 0.72 LRRK2 (0.47) CSF1RSTK4STK3LRRK2LMNA
SCHEMBL1439667 0.72 KDM4E (0.58) CSF1RSTK4STK3LRRK2PIK3CA
SCHEMBL21467056 0.72 PIK3CD (0.55) CSF1RFLT1KDRFLT3LRRK2
SCHEMBL20093467 0.72 JAK2 (0.52) FLT1FLT4KDRFLT3STK4
SCHEMBL3782102 0.71 PIK3CD (0.57) CSF1RKITPDGFRAFLT1FLT4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10322130-B2 Substituted chromenones as modulators of protein kinases RHIZEN PHARMACEUTICALS SA (CH) 2019-06-18 US disclosed
US-20190105324-A9 SUBSTITUTED CHROMENONES AS MODULATORS OF PROTEIN KINASES RHIZEN PHARMACEUTICALS AG (CH) 2019-04-11 US disclosed
US-20180110783-A1 NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES RHIZEN PHARMACEUTICALS SA (CH) 2018-04-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190105324-A9 SUBSTITUTED CHROMENONES AS MODULATORS OF PROTEIN KINASES PRKCA, PRKCH, PRKAR2B CSF1R 2967/4885KIT 1122/4885PDGFRA 834/4885
US-20180110783-A1 NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES PRKCA, PRKCH, PRKCB CSF1R 2530/4885KIT 1585/4885PDGFRA 937/4885
US-10322130-B2 Substituted chromenones as modulators of protein kinases MAP3K1, CSNK1A1, MAP3K2 CSF1R 1545/4885KIT 804/4885PDGFRA 906/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.